Healthcare advise should always be sought, especially if already taking prescription medication
JACC Cardiovasc
Tirzepatide Side Effects# Well-characterized from Phase 3 (SURPASS, SURMOUNT) trials and post-market surveillance: Gastrointestinal : Nausea (12-33%), diarrhea (12-21%), vomiting (5-12%), constipation (6-11%) Decreased appetite : Common and expected pharmacological effect Injection site reactions : Mild, occurring in 2-5% of patients Pancreatitis : Rare
Enhanced metabolic efficiency: Retatrutide may help the body shift towards using stored fat for energy more often, rather than depending solely on glucose
Use daily or as needed
Beauvais A, Schmidt C, Guadagnini S, Roux P, Perret E, Henry C, Paris S, Mallet A, Prvost MC, Latg JP (2007) An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus